compounded tirzepatide online prescription Weight Loss Program doctor-only Dose:Monthly Subscription (Any Dose) 1 and GIP therapy GLP-1 Constipation Relief: Safe

compounded tirzepatide online prescription Weight Loss Program doctor-only Dose:Monthly Subscription (Any Dose) 1 and GIP therapy GLP-1 Constipation Relief: Safe

GLP-1 Constipation Relief: Safe Laxative Use | PlexusDx

Consistency allows your body to adjust gradually and helps minimize side effects

doctor-only

Dose:Monthly Subscription (Any Dose)

Use this decision framework: Choose tirzepatide (Zepbound or compounded) if: You have not tried a GLP-1 medication before and want the most effective option based on current evidence You have tried semaglutide and experienced a weight loss plateau after 3 to 6 months You have tried semaglutide and had intolerable nausea or diarrhea (tirzepatide may be better tolerated) You have both obesity and type 2 diabetes and need maximal A1C reduction Cost is not a limiting factor (or you have access to compounded tirzepatide at similar cost to semaglutide) Choose semaglutide (Wegovy, Ozempic, or compounded) if: You have tried tirzepatide and experienced intolerable side effects You prefer an oral option (Rybelsus, though less effective than injections) Your insurance covers semaglutide but not tirzepatide You have a history of pancreatitis (both medications carry risk, but semaglutide has more long-term safety data) You are already on semaglutide and achieving your goals (no reason to switch) Consider switching from semaglutide to tirzepatide if: Weight loss has stalled for 8+ weeks despite adherence and dose optimization You are at maximum semaglutide dose (2.4 mg) and still not at goal weight Side effects on semaglutide are limiting your ability to stay on treatment Consider switching from tirzepatide to semaglutide if: Nausea, vomiting, or diarrhea is severe and persistent despite dose reduction and management strategies Cost is prohibitive (semaglutide is sometimes less expensive in compounded form) You develop contraindications specific to GIP agonism (rare, but theoretically possible) When neither is appropriate: History of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (both medications are contraindicated) Pregnancy or planning pregnancy (both are pregnancy category unknown, not recommended) Severe gastroparesis (both medications slow gastric emptying further) History of severe pancreatitis (relative contraindication, requires provider judgment) The decision should be made collaboratively with a provider who can assess your medical history, weight loss goals, side effect tolerance, and insurance coverage

1 and GIP therapy